[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Joseph E. Whitters net worth and biography

Joseph Whitters Biography and Net Worth

Director of Accuray

Joseph E. Whitters has served as a member of our Board of Directors since July 2018. Mr. Whitters has been an advisor/consultant to Frazier Healthcare, a private equity firm, since 2005. From 1986 to 2005, Mr. Whitters served in various capacities with First Health Group Corp., a publicly traded managed care company, most recently as its Chief Financial Officer. He also previously served as the Controller for United Healthcare Corp. from 1984 to 1986. Prior to that, Mr. Whitters served as the Manager of Accounting and Taxation for Overland Express, a publicly traded trucking company, and he began his career in public accounting with Peat Marwick (now KPMG). Mr. Whitters currently serves as a member of the board of directors of Cutera Inc. and chairman of the board of PRGX Global, Inc. Previously, Mr. Whitters served on the boards of directors and audit committees of various public companies, including Analogic Corporation, InfuSystem Holdings, Inc. and Omnicell Technologies. Mr. Whitters has also been an advisor or board member of several private companies. Mr. Whitters holds a B.A. in Accounting from Luther College.

What is Joseph E. Whitters' net worth?: The estimated net worth of Joseph E. Whitters is at least $945,448.05 as of May 28th, 2024. Mr. Whitters owns 511,053 shares of Accuray stock worth more than $945,448 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Whitters may own. Learn More about Joseph E. Whitters' net worth.
How do I contact Joseph E. Whitters?: The corporate mailing address for Mr. Whitters and other Accuray executives is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. Accuray can also be reached via phone at (408) 716-4600 and via email at [email protected]. Learn More on Joseph E. Whitters' contact information.
Has Joseph E. Whitters been buying or selling shares of Accuray?: Joseph E. Whitters has not been actively trading shares of Accuray during the last ninety days. Most recently, on Tuesday, May 28th, Joseph E. Whitters bought 50,000 shares of Accuray stock. The stock was acquired at an average cost of $1.54 per share, with a total value of $77,000.00. Following the completion of the transaction, the director now directly owns 511,053 shares of the company's stock, valued at $787,021.62. Learn More on Joseph E. Whitters' trading history.
Who are Accuray's active insiders?: Accuray's insider roster includes Jesse Chew (SVP), Brandon Green (CFO), Michael Hoge (VP), Joshua Levine (CEO), Byron Scott (Director), Patrick Spine (SVP), Joseph Whitters (Director), and Suzanne Winter (President). Learn More on Accuray's active insiders.
Are insiders buying or selling shares of Accuray?: In the last year, Accuray insiders bought shares 1 times. They purchased a total of 50,000 shares worth more than $77,000.00. In the last year, insiders at the medical equipment provider sold shares 8 times. They sold a total of 140,247 shares worth more than $345,270.83. The most recent insider tranaction occured on September, 4th when CFO Ali Pervaiz sold 8,404 shares worth more than $17,312.24. Insiders at Accuray own 4.2% of the company. Learn More about insider trades at Accuray.
Information on this page was last updated on 9/4/2024.

Joseph E. Whitters Insider Trading History at Accuray

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/28/2024	Buy	50,000	$1.54	$77,000.00	511,053
8/16/2021	Buy	17,500	$3.64	$63,700.00	314,210
2/1/2021	Buy	20,000	$5.02	$100,400.00	296,710
11/11/2020	Buy	50,000	$3.46	$173,000.00	243,078
11/1/2019	Buy	25,000	$2.60	$65,000.00	144,377
9/4/2019	Buy	12,500	$2.62	$32,750.00	116,780

Joseph E. Whitters Buying and Selling Activity at Accuray

Accuray Company Overview

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Today's Range

Now: $1.85

$1.81

$1.89

50 Day Range

MA: $1.85

$1.70

$2.19

2 Week Range

Now: $1.85

$1.40

$3.05

Volume

371,193 shs

Average Volume

660,750 shs

Market Capitalization

$186.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4